HopeStage
Back to all studies
CompletedNCT04130958

Brain Stimulation and Biomarkers for Suicide Prevention

About this titleRead the official source — NCT04130958
Device studyAges 18–65United StatesPersonality disorders
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 65 years.

Listed locations
BostonSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: November 1, 2023
Recruitment status
Completed
Enrollment listed in the registry
75
Sponsor
Massachusetts General Hospital
Sponsor type
Hospital / academic medical center
Study type
Device
Intervention type
DEVICE
Study phase
Not clearly listed
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT04130958
Official title
Show the full official title

Circuit-Based Approach to Suicide: Biomarkers, Predictors, and Novel Therapeutics

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Boston

Registry details
Registry conditions (original wording)

Major Depressive Episode; Borderline Personality Disorder; Suicide

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Massachusetts General Hospital, a hospital or academic medical center.

Who was this study for?

Listed age limits: 18 years to 65 years.

Want to explore more studies?

Explore studies